E2 inhibitor (Seragen)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameE2 inhibitor (Seragen)
Drug Alias Nametranscription factor inhibitor (Seragen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeragen Inc
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A